Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-07-040627
Filing Date
2007-07-03
Accepted
2007-07-03 16:03:17
Documents
1
Period of Report
2007-07-01

Document Format Files

Seq Description Document Type Size
1 MAIN DOCUMENT DESCRIPTION bny36789_bny01pmr.html 4  
1 MAIN DOCUMENT DESCRIPTION bny36789_bny01pmr.xml 4 11017
  Complete submission text file 0001209191-07-040627.txt   13169
Mailing Address 685 ROUTE 202/206 ATT: GENERAL COUNSEL BRIDGEWATER NJ 08807
Business Address 685 ROUTE 202/206 BRIDGEWATER NJ 08807 908 541 8671
ENZON PHARMACEUTICALS INC (Issuer) CIK: 0000727510 (see all company filings)

EIN.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ENZON PHARM.,685 RTE 202/206 BRIDGEWATER NJ 08807
Business Address 908-541-8650
Renfro Phillip M (Reporting) CIK: 0001313575 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-12957 | Film No.: 07960866